This rarity is consistent with a previously described model wherein HPV-driven cancer is associated with high HPV viral load, wild type p53, and overexpression of p16 as a consequence of HPV oncoproteins that inactivate p53 and Rb. This evidence concerns the gene CDKN2A and cancer.